Anna Carter
- Hematology top 5%
- Multiple Myeloma Research and Treatments 9
- Acute Myeloid Leukemia Research 4
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
- Blood disorders and treatments 2
-
- Cancer Treatment and Pharmacology 3
-
- HIV/AIDS Research and Interventions 3
-
- Immune Cell Function and Interaction 2
- Immune Response and Inflammation 2
- Co-authors
- I. TatarskyBogusław MachalińskiMariusz Z. RatajczakJanina RatajczakWojciech MarliczMarcin MajkaJake P. MannIrit Hocherman
- Cited by
- HematologyGeneticsOncology
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Anna Carter
23 papers receiving 399 citations
Peers
Comparison fields: 5 of 63
- Hematology 214
- Genetics 105
- Oncology 98
- Hepatology 25
- Physiology 13
Countries citing papers authored by Anna Carter
This map shows the geographic impact of Anna Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Carter more than expected).
Fields of papers citing papers by Anna Carter
This network shows the impact of papers produced by Anna Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Carter. The network helps show where Anna Carter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Carter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2021 | 6 | |
| 3 | 2018 | 49 | |
| 4 | 2017 | 5 | |
| 5 | Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells. | 2000 | 28 |
| 6 | 1998 | 75 | |
| 7 | 1997 | 30 | |
| 8 | 1996 | 18 | |
| 9 | 1996 | 11 | |
| 10 | 1995 | 2 | |
| 11 | 1994 | 3 | |
| 12 | 1992 | 18 | |
| 13 | 1988 | 7 | |
| 14 | 1987 | 53 | |
| 15 | 1987 | 6 | |
| 16 | 1986 | 9 | |
| 17 | 1985 | 5 | |
| 18 | 1984 | 3 | |
| 19 | 1984 | 11 | |
| 20 | 1983 | 0 |
About Anna Carter
Anna Carter is a scholar working on Hematology, Genetics, Immunology, Hepatology and Physiology, having authored 24 papers that have together received 410 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Treatment and Pharmacology (3 papers), HIV/AIDS Research and Interventions (3 papers), Blood disorders and treatments (2 papers), Immune Cell Function and Interaction (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Hematology (214 citations), Genetics (105 citations), Oncology (98 citations), Hepatology (25 citations) and Physiology (13 citations). Anna Carter has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include I. Tatarsky, Bogusław Machaliński, Mariusz Z. Ratajczak, Janina Ratajczak, Wojciech Marlicz, Marcin Majka, Jake P. Mann, Irit Hocherman, Jiali Gao and Shai Linn. Their work appears in journals such as British Journal of Haematology, Cancer, Journal of Hepatology, Journal of the International AIDS Society and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.